Apellis Pharmaceuticals (NASDAQ:APLS) Issues Quarterly Earnings Results, Misses Estimates By $0.14 EPS
Apellis Pharmaceuticals (NASDAQ:APLS – Get Free Report) issued its quarterly earnings data on Tuesday. The company reported ($0.46) earnings per share for the quarter, missing the consensus estimate of ($0.32) by ($0.14), Briefing.com reports. Apellis Pharmaceuticals had a negative return on equity of 138.32% and a negative net margin of 52.99%. The business had revenue […]
More Stories
WisdomTree Global ex U.S. Quality Dividend Growth Fund (NYSEARCA:DNL) Trading 2% Higher – Here’s Why
WisdomTree Global ex U.S. Quality Dividend Growth Fund (NYSEARCA:DNL – Get Free Report) shares rose 2% on Thursday . The...
First Trust NASDAQ 100 Ex-Technology Sector Index Fund (NASDAQ:QQXT) Trading 0.6% Higher – What’s Next?
Shares of First Trust NASDAQ 100 Ex-Technology Sector Index Fund (NASDAQ:QQXT – Get Free Report) rose 0.6% on Thursday ....
First Trust United Kingdom AlphaDEX Fund (NASDAQ:FKU) Trading 0.8% Higher – Time to Buy?
First Trust United Kingdom AlphaDEX Fund (NASDAQ:FKU – Get Free Report)’s stock price rose 0.8% on Thursday . The company...
Troilus Gold (CVE:TLG) Shares Up 18.6% – Time to Buy?
Troilus Gold Corp. (CVE:TLG – Get Free Report)’s share price traded up 18.6% during trading on Thursday . The company...
Head to Head Survey: TaskUs (NASDAQ:TASK) vs. Lytus Technologies Holdings PTV. (NASDAQ:LYT)
TaskUs (NASDAQ:TASK – Get Free Report) and Lytus Technologies Holdings PTV. (NASDAQ:LYT – Get Free Report) are both small-cap computer...
Cyberloq Technologies (NASDAQ:CLOQ) Trading Down 4.1% – Here’s What Happened
Shares of Cyberloq Technologies, Inc. (NASDAQ:CLOQ – Get Free Report) dropped 4.1% during mid-day trading on Thursday . The company...